A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic

BACKGROUND: The coronavirus pandemic (Covid-19) presents a variety of challenges for ongoing clinical trials, including an inevitably higher rate of missing outcome data, with new and non-standard reasons for missingness. International drug trial guidelines recommend trialists review plans for handl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cro, Suzie, Morris, Tim P., Kahan, Brennan C., Cornelius, Victoria R., Carpenter, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422467/
https://www.ncbi.nlm.nih.gov/pubmed/32787782
http://dx.doi.org/10.1186/s12874-020-01089-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422467/
https://www.ncbi.nlm.nih.gov/pubmed/32787782
http://dx.doi.org/10.1186/s12874-020-01089-6

Ejemplares similares